DOPE-mPEG is a compound that has gained significant attention in the field of pharmaceutical research and development due to its unique chemical structure and functional properties. This compound is a derivative of dioleoylphosphatidylethanolamine (DOPE), which is a naturally occurring phospholipid found in cell membranes.
DOPE-mPEG is a modified form of DOPE that has been covalently linked with polyethylene glycol (PEG) and methyl groups. PEG is a hydrophilic polymer that is widely used in pharmaceuticals to improve the solubility, bioavailability, and pharmacokinetics of drugs. The addition of PEG to DOPE creates a PEGylated lipid that has improved stability and enhanced drug delivery capabilities.
Methyl groups are also incorporated into DOPE-mPEG, which serves to increase the lipophilicity of the compound. This lipophilicity is important for the incorporation of the compound into cell membranes, where it can interact with cellular components and exert its pharmacological effects.
DOPE-mPEG has been used in a variety of pharmaceutical applications, including drug delivery, gene therapy, and vaccine development. In drug delivery, DOPE-PEG-Methyl has been used to improve the solubility and bioavailability of poorly soluble drugs, as well as to target specific tissues or cells. In gene therapy, DOPE-PEG-Methyl has been used as a vector for the delivery of genetic material into cells. And in vaccine development, DOPE-PEG-Methyl has been used as an adjuvant to enhance the immune response to vaccines.
|AP13708||DOPE-mPEG, MW 1K||1000||≥95%||Pricing|
|AP13716||DOPE-mPEG, MW 2K||2000||≥95%||Pricing|
|AP13722||DOPE-mPEG, MW 5K||5000||≥95%||Pricing|